Precigen
PGEN
#5312
Rank
NZ$2.78 B
Marketcap
NZ$7.77
Share price
2.64%
Change (1 day)
3.38%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): NZ$44.83 Million

According to Precigen's latest financial reports the company's current earnings are NZ$0.15 Billion. In 2025 the company made an earning of -NZ$0.46 Billion a decrease over its 2024 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$44.83 M-109.83%
2025 -NZ$0.46 Billion95.77%
2024 -NZ$0.24 Billion32.86%
2023 -NZ$0.18 Billion20.5%
2022 -NZ$0.15 Billion-23.33%
2021 -NZ$0.19 Billion60.11%
2020 -NZ$0.12 Billion-65.1%
2019 -NZ$0.34 Billion-65.19%
2018 -NZ$0.98 Billion313.44%
2017 -NZ$0.24 Billion-33.2%
2016 -NZ$0.36 Billion123.22%
2015 -NZ$0.16 Billion1.47%
2014 -NZ$0.16 Billion109.54%
2013 -NZ$74.45 Million-50.04%
2012 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-NZ$4.53 Million-110.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-NZ$0.14 Billion-396.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-NZ$0.41 Billion-1,008.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-NZ$0.17 Billion-465.61% Jersey